(Q47370570)

15 January 2018

title

Need for weight management among postmenopausal early breast cancer patients receiving adjuvant endocrine therapy (English)

1 reference

15 January 2018

author name string

Michelle Harvie

series ordinal

1

1 reference

15 January 2018

Tony Howell

series ordinal

2

1 reference

15 January 2018

publication date

1 September 2005

1 reference

15 January 2018

published in

Women's Health

1 reference

15 January 2018

volume

1

1 reference

15 January 2018

issue

2

1 reference

15 January 2018

page(s)

205-222

1 reference

15 January 2018

Dual effects of weight and weight gain on breast cancer risk

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Probabilities of death from breast cancer and other causes among female breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Declining mortality from breast cancer in Yorkshire, 1983-1998: extent and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Weight gain in women with localized breast cancer--a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Breast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Body size and breast cancer prognosis: a critical review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Body weight correlates with mortality in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Adiposity and sex hormones in postmenopausal breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Weight, weight gain, and survival after breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Waist-to-hip ratio and breast cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Aging may be associated with concentrations of tamoxifen and its metabolites in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Tamoxifen therapy for breast cancer and endometrial cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Obesity and disease management: effects of weight loss on comorbid conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Influence of tamoxifen on carotid intima-media thickness in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Sequential changes in serum triglyceride levels during adjuvant tamoxifen therapy in breast cancer patients and the effect of dose reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Meta-analysis of vascular and neoplastic events associated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

A prospective study of weight change and health-related quality of life in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Arm edema in conservatively managed breast cancer: obesity is a major predictive factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Overweight, obesity, and blood pressure: the effects of modest weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Should we recommend low-fat diets for obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Dietary fat and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

A randomized trial of a low-carbohydrate diet for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Glycemic load and chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Obesity, adipocytokines, and insulin resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Nutrition and survival after the diagnosis of breast cancer: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Fruit and vegetable intake and risk of major chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Alcohol consumption and mortality: modelling risks for men and women at different ages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Weight gain in early-stage breast cancer: where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Physical Activity and Survival After Breast Cancer Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Exercise in Cancer Survivors: An Overview of Research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Cost effectiveness of a community based exercise programme in over 65 year olds: cluster randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Current approaches to obesity management in UK Primary Care: the Counterweight Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Achieving substantial changes in eating behavior among women previously treated for breast cancer--an overview of the intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Design of FRESH START: a randomized trial of exercise and diet among cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Adherence to moderate-intensity exercise during breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Psychiatric morbidity and its recognition by doctors in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Serum testosterone levels and breast cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

C-reactive protein levels are not associated with increased risk for colorectal cancer in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Breast cancer treatment in older women: does getting what you want improve your long-term body image and mental health?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Evidence-based guidelines for cardiovascular disease prevention in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Effects of a 6-week hypocaloric diet on changes in body composition, hunger, and subsequent weight regain in healthy young and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

A comparison of physical activity of posttreatment breast cancer survivors and noncancer controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Leading the Way in Exercise and Diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

Randomized Controlled Trial of Exercise Training in Postmenopausal Breast Cancer Survivors: Cardiopulmonary and Quality of Life Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.205

21 January 2018

Identifiers

DOI

10.2217/17455057.1.2.205

1 reference

15 January 2018

1 reference

15 January 2018